This Opinion article discusses many controversial issues surrounding the connections of progestogens, which stimulate the progesterone receptor, to breast cancer risk and their possible therapeutic use in breast cancer.
- Jason S. Carroll
- Theresa E. Hickey
- Wayne D. Tilley